Dawn Christine Maroney Sells 228,152 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 228,152 shares of the stock in a transaction that occurred on Tuesday, January 6th. The stock was sold at an average price of $21.33, for a total transaction of $4,866,482.16. Following the completion of the sale, the president owned 1,057,015 shares in the company, valued at $22,546,129.95. This represents a 17.75% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Friday, January 2nd, Dawn Christine Maroney sold 100,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.03, for a total value of $2,003,000.00.
• On Monday, December 29th, Dawn Christine Maroney sold 282,070 shares of Alignment Healthcare stock. The shares were sold at an average price of $18.74, for a total value of $5,285,991.80.
• On Monday, December 15th, Dawn Christine Maroney sold 113,319 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.01, for a total transaction of $2,267,513.19.
• On Friday, December 12th, Dawn Christine Maroney sold 16,681 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.02, for a total transaction of $333,953.62.

Alignment Healthcare Price Performance

NASDAQ:ALHC traded up $0.30 during midday trading on Tuesday, hitting $21.30. The company had a trading volume of 3,772,138 shares, compared to its average volume of 3,136,679. The company has a market capitalization of $4.26 billion, a PE ratio of -177.50, a P/E/G ratio of 5.81 and a beta of 1.16. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.99. Alignment Healthcare, Inc. has a 52-week low of $11.35 and a 52-week high of $21.65. The stock’s fifty day moving average price is $18.43 and its 200-day moving average price is $16.38.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.03. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The business had revenue of $993.70 million for the quarter, compared to the consensus estimate of $980.90 million. During the same quarter last year, the business posted ($0.14) earnings per share. The company’s revenue for the quarter was up 43.5% on a year-over-year basis. As a group, research analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages recently commented on ALHC. Piper Sandler lifted their target price on shares of Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a research report on Tuesday. JPMorgan Chase & Co. raised their price objective on Alignment Healthcare from $20.00 to $23.00 and gave the company an “overweight” rating in a research note on Wednesday, December 17th. KeyCorp reissued an “overweight” rating on shares of Alignment Healthcare in a research note on Monday, November 24th. Barclays increased their target price on Alignment Healthcare from $13.00 to $18.00 and gave the company an “equal weight” rating in a report on Friday, October 31st. Finally, Wall Street Zen raised Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $21.25.

Institutional Trading of Alignment Healthcare

Large investors have recently modified their holdings of the business. Larson Financial Group LLC bought a new position in Alignment Healthcare during the 3rd quarter valued at approximately $33,000. SBI Securities Co. Ltd. increased its stake in shares of Alignment Healthcare by 4,868.9% during the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock valued at $42,000 after buying an additional 2,970 shares during the period. GAMMA Investing LLC raised its holdings in shares of Alignment Healthcare by 83.8% during the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock valued at $43,000 after acquiring an additional 987 shares in the last quarter. KBC Group NV purchased a new stake in Alignment Healthcare in the second quarter worth $44,000. Finally, Signaturefd LLC lifted its stake in Alignment Healthcare by 142.6% in the second quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock worth $53,000 after acquiring an additional 2,215 shares during the period. 86.19% of the stock is owned by institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.